Vue transversale globale

Toutes les maladies

Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.

Périmètre

Filtrer toute la vue

Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.

Tout réinitialiser Actualisation…
Essais et traitements4050Données cliniques et programmes
Recherches et trouvailles21Pipeline scientifique
Publications4595Références reliées aux maladies
Pistes exploratoires0Hypothèses non validées
8666 résultats correspondants · 41 visibles sur cette page dans le périmètre Toutes les maladies
Niveau clinique

Études et traitements 4050

Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
anti-CD19-CAR-T cells NCT06420154 · The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refra… Sclérose en plaques Immunomodulation · Thérapie cellulaire Phase 1 NOT_YET_RECRUITING This is an investigator-initiated trial to evaluate the safety and efficac… À vérifier ClinicalTrials.gov 2026-09-20 04:37:27 Détail
ASP2802 NCT06248086 · A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell L… Sclérose en plaques Immunomodulation · Thérapie cellulaire Phase 1 TERMINATED CAR-T cell therapy is a type of treatment for people with certain lymphoma… À vérifier ClinicalTrials.gov 2026-09-20 04:37:27 Détail
Bexxar NCT00434629 · Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Ce… Sclérose en plaques À vérifier Phase 1 COMPLETED Patients with B-cell lymphoma who relapse after autologous transplant tend… À vérifier ClinicalTrials.gov 2026-09-20 04:37:27 Détail
CD19/CD22 CAR-T NCT04499573 · Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B… Sclérose en plaques Thérapie cellulaire Phase 1/2 ACTIVE_NOT_RECRUITING The purpose of this study is to evaluate the safety and efficiency of auto… À vérifier ClinicalTrials.gov 2026-09-20 04:37:27 Détail
cemacabtagene ansegedleucel NCT06500273 · ALPHA3 — Consolidation of First-Line MRD+ Remission With Cema-cel in Patients Wi… Sclérose en plaques À vérifier Phase 2 RECRUITING This is a randomized, open-label study in adult patients who have complete… À vérifier ClinicalTrials.gov 2026-09-20 04:37:27 Détail
CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Deplet… NCT03810196 · CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post… Sclérose en plaques Immunomodulation · Thérapie cellulaire Non applicable RECRUITING The major morbidities of allogeneic hematopoietic stem cell transplant wit… À vérifier ClinicalTrials.gov 2026-09-20 04:37:27 Détail
KYV-101, an autologous fully-human anti-CD19 CAR T-cell immunotherapy NCT06590545 · IDEAL — Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis Sclérose en plaques Thérapie cellulaire Phase 1/2 NOT_YET_RECRUITING The goal of this phase I/II clinical trial is to investigate anti-CD 19 ch… À vérifier ClinicalTrials.gov 2026-09-20 04:37:27 Détail
rapcabtagene autoleucel (YTB323) NCT07443137 · CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study) Sclérose en plaques Immunomodulation · Thérapie cellulaire Phase 1 NOT_YET_RECRUITING This is an open-label, multi-center, non-confirmatory study to assess the… À vérifier ClinicalTrials.gov 2026-09-20 04:37:27 Détail
rondecabtagene autoleucel NCT07188558 · PiNACLE-H2H — A Study to Investigate Ronde-cel Versus Investigator's Choice CD19… Sclérose en plaques Immunomodulation · Thérapie cellulaire Phase 3 RECRUITING This Phase 3 study compares rondecabtagene autoleucel (ronde-cel), a dual-… À vérifier ClinicalTrials.gov 2026-09-20 04:37:27 Détail
TC011 single-arm NCT07360288 · TC011_FL_201 — Efficacy and Safety of TC011 in Relapsed or Refractory Follicular… Sclérose en plaques Thérapie cellulaire Phase 2 NOT_YET_RECRUITING This Phase II, multi-center, single-arm, open-label study evaluates the ef… À vérifier ClinicalTrials.gov 2026-09-20 04:37:27 Détail
ThisCART19A with Dose Level 1 NCT05691153 · ThisCART19A for B-NHL Relapsed After Auto-CAR T Sclérose en plaques Thérapie cellulaire Phase 1 UNKNOWN This is a phase 1, single-center, dose selection study to evaluate the eff… À vérifier ClinicalTrials.gov 2026-09-20 04:37:27 Détail
Rituximab NCT03636503 · Rituximab + Immunotherapy in Follicular Lymphoma Sclérose en plaques À vérifier Phase 1 TERMINATED The primary objective of this phase III trial is to investigate if Rituxim… À vérifier ClinicalTrials.gov 2026-09-20 04:37:26 Détail
Rituximab NCT00006669 · Rituximab Followed by Combination Chemotherapy in Treating Patients With Refract… Sclérose en plaques À vérifier Phase 2 WITHDRAWN The primary objective of this phase III trial is to investigate if Rituxim… À vérifier ClinicalTrials.gov 2026-09-20 04:37:26 Détail
SCT400 plus CHOP NCT02772822 · A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxyd… Sclérose en plaques Immunomodulation Phase 3 UNKNOWN The primary objective of the study is to assess the efficiency of SCT400 p… À vérifier ClinicalTrials.gov 2026-09-20 04:37:26 Détail
Armored and GPC3-targeted autologous CAR T-cell NCT06590246 · A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocell… Sclérose en plaques À vérifier Phase 1/2 RECRUITING This single-arm, open-label multicenter Phase I/II study will evaluate the… À vérifier ClinicalTrials.gov 2026-09-20 04:37:25 Détail
C-CAR031 NCT05155189 · A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031… Sclérose en plaques Immunomodulation · Thérapie cellulaire Phase 1 RECRUITING A study that aimed to assess the safety and anti-tumor activity of CCAR031… À vérifier ClinicalTrials.gov 2026-09-20 04:37:25 Détail
C-CAR031 NCT07444281 · An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Ad… Sclérose en plaques À vérifier Phase 1 RECRUITING A study that aimed to assess the safety and anti-tumor activity of CCAR031… À vérifier ClinicalTrials.gov 2026-09-20 04:37:25 Détail
CD19/CD20-directed Chimeric Antigen Receptor T Cells NCT05149391 · A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgk… Sclérose en plaques Immunomodulation Phase 1 COMPLETED This is a single-center, open-label study to evaluate the safety and effic… À vérifier ClinicalTrials.gov 2026-09-20 04:37:25 Détail
Prizloncabtagene Autoleucel NCT04317885 · A Study Evaluating Safety and Efficacy of C-CAR039 Treatment in NHL Subjects Sclérose en plaques À vérifier Phase 1 COMPLETED The trial is a single arm, single-center, non-randomized phase I clinical… À vérifier ClinicalTrials.gov 2026-09-20 04:37:25 Détail
Prizloncabtagene Autoleucel NCT04693676 · A Study of C-CAR039 Treatment in Subjects With r/r NHL Subjects Non-Hodgkin's Ly… Sclérose en plaques À vérifier Phase 1 UNKNOWN The trial is a single arm, single-center, non-randomized phase I clinical… À vérifier ClinicalTrials.gov 2026-09-20 04:37:25 Détail
Découverte scientifique

Recherches et trouvailles 21

Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation Sclérose latérale amyotrophique Neuroprotection · Immunomodulation Découverte fondamentale Exploratoire Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… Revue scientifique 2024-07-01 Détail
Bibliographie

Publications 4595

Références bibliographiques de la base locale et accès à leur source originale.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Is inpatient monitoring necessary in pediatric patients with comorbid… Lighting Intervention Therapy · PMID 42469506 Maladie d’Alzheimer À vérifier Publication PubMed Voir la publication source Children and young adults with severe pre-existing conditions frequently require dental treatment under general anesthe… Oral and maxillofacial surgery 2026-07-18 15:46:22 Source
36th International Symposium on Intensive Care and Emergency Medicine… VALID — Volunteers Adding Life in Dementia · PMID 27885969 Hypertension artérielle · Cancer Neuroprotection · Ralentissement de la progression · Immunomodulation · Traitem… Publication PubMed Voir la publication source P001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP… Critical care (London, England) 2026-07-18 15:46:21 Source
The role of perseverance on the association between resilience and su… Couples Coping With Alzheimer's Disease · PMID 42455702 Cancer À vérifier Publication PubMed Voir la publication source Although resilience and perseverance are known for their physical health benefits, evidence on their effects on cogniti… Journal of psychosocial oncology 2026-07-18 15:46:09 Source
Donepezil-induced manic episodes in two patients with different types… Donepezil · PMID 42459577 Maladie d’Alzheimer À vérifier Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hast… 2026-07-18 15:46:07 Source
Individualized prediction of heroin cue-induced craving using task-ba… Intermittent theta burst stimulation · PMID 42469381 Maladie d’Alzheimer · Myopathies · Maladie de Parkinson · Maladie d’A… À vérifier Publication PubMed Voir la publication source Cue-induced craving is a core driver of addiction and relapse, and its significant heterogeneity represents a major bar… NPJ digital medicine 2026-07-18 15:46:07 Source
Intermittent theta burst stimulation modulates mirror visual feedback… Intermittent theta burst stimulation · PMID 42469892 Maladie d’Alzheimer · Myopathies · Maladie de Parkinson · Maladie d’A… À vérifier Publication PubMed Voir la publication source Theta burst stimulation (TBS) and mirror visual feedback (MVF) reduce interhemispheric asymmetry in both hemispheres, w… Journal of neuroengineering and rehabilitation 2026-07-18 15:46:07 Source
Rational design and synthesis of dispiroindene-pyrrolidinedione scaff… Donepezil · PMID 42462519 Maladie d’Alzheimer À vérifier Publication PubMed Voir la publication source Addressing the urgent need for multi-target therapies in Alzheimer's disease, we report the rational design and one-pot… Bioorganic chemistry 2026-07-18 15:46:07 Source
Incidence study of precocious puberty in the population of the state… GnRH, gonadorelin acetate · PMID 42468908 Maladie d’Alzheimer À vérifier Publication PubMed Voir la publication source To evaluate the incidence and epidemiological, clinical, and laboratory characteristics of Central Precocious Puberty (… Jornal de pediatria 2026-07-18 15:46:05 Source
Pulmonary alveolar proteinosis diagnosed during leuprorelin acetate t… GnRH, gonadorelin acetate · PMID 42469731 Maladie d’Alzheimer Traitement symptomatique Publication PubMed Voir la publication source Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disorder characterized by impaired surfactant clearance due to… BMC pulmonary medicine 2026-07-18 15:46:05 Source
Efficacy and safety of IPX203 in Parkinson's patients: a systematic r… IR CD-LD · PMID 41565857 Maladie de Parkinson Traitement symptomatique Publication PubMed Voir la publication source Parkinson's disease (PD) is one of the most common neurodegenerative disorders, characterized by motor symptoms in addi… Neurological sciences : official journal of the Italia… 2026-07-18 15:46:02 Source
How to dose extended-release carbidopa-levodopa capsules (IPX203, CRE… IR CD-LD · PMID 40799912 Maladie de Parkinson À vérifier Publication PubMed Voir la publication source IPX203 (CREXONT®) is a novel, oral, extended-release (ER) carbidopa-levodopa (CD-LD) formulation, designed to rapidly a… Clinical parkinsonism & related disorders 2026-07-18 15:46:02 Source
Plant-Based Therapies to Ameliorate Neuroinflammation in Parkinson's… IPX066 · PMID 40237742 Maladie d’Alzheimer · Maladie de Parkinson Neuroprotection · Immunomodulation · Thérapie génique Publication PubMed Voir la publication source Neuroinflammation plays a crucial role in the etiology of neurodegenerative diseases such as Parkinson's disease (PD),… Chemistry & biodiversity 2026-07-18 15:46:01 Source
Treatment strategies for motor fluctuations in Parkinson's disease: a… IPX066 · PMID 41415581 Maladie de Parkinson Ralentissement de la progression Publication PubMed Voir la publication source Motor fluctuations represent a major therapeutic challenge in Parkinson's disease, particularly among individuals on lo… Frontiers in pharmacology 2026-07-18 15:46:01 Source
Can table tennis protect the aging brain? A systematic review and met… Investigation of Dual-Task Exercise's Effect in Parkinson's Disease · PMID 41197370 Maladie d’Alzheimer · Maladie de Parkinson À vérifier Publication PubMed Voir la publication source Table tennis (TT) is an increasingly investigated intervention for supporting cognitive, motor, and psychosocial functi… Acta psychologica 2026-07-18 15:46:00 Source
Can table tennis protect the aging brain? A systematic review and met… Investigation of Dual-Task Exercise's Effect in Parkinson's Disease · PMID 42214165 Maladie d’Alzheimer · Maladie de Parkinson À vérifier Publication PubMed Voir la publication source Table tennis (TT) is an increasingly investigated intervention for supporting cognitive, motor, and psychosocial functi… Acta psychologica 2026-07-18 15:46:00 Source
Effectiveness of intermittent hypoxia on muscle recovery in rats: A s… Aerobic exercise · PMID 42464793 Maladie de Parkinson Remyélinisation indirecte / réparation · Neuroprotection · Traitement symptomat… Publication PubMed Voir la publication source The objective of this review was to synthesize evidence from animal models on the effects of intermittent hypobaric hyp… Animal models and experimental medicine 2026-07-18 15:45:58 Source
Resistance Training Improves Cardiovascular Health in Postmenopausal… Aerobic exercise · PMID 42470140 Maladie de Parkinson À vérifier Publication PubMed Voir la publication source Postmenopausal women (PW) experience hemodynamic and autonomic alterations that increase cardiovascular risk. While aer… Journal of applied physiology (Bethesda, Md. : 1985) 2026-07-18 15:45:58 Source
A role for the syntaxin protein in post-wound cell survival. Sorbitol · PMID 42455620 Maladie d’Alzheimer · Maladie de Parkinson Immunomodulation · Thérapie génique Publication PubMed Voir la publication source Wound repair is an essential biological process that occurs both in tissues and single cells. In free-living single-cel… Molecular biology of the cell 2026-07-18 15:45:54 Source
Belgian endive-derived biostimulant activity in , lettuce, and sweet… Sorbitol · PMID 42459385 Maladie d’Alzheimer · Maladie de Parkinson À vérifier Publication PubMed Voir la publication source Belgian endive-derived biostimulant (BEE) has been previously shown to enhance root and shoot growth of and in culturin… Frontiers in plant science 2026-07-18 15:45:54 Source
Continuous theta-burst stimulation over the right DLPFC modulates cen… Continuous theta burst stimulation · PMID 42468853 Maladie de Parkinson Traitement symptomatique Publication PubMed Voir la publication source Previous studies suggest that transcranial magnetic stimulation exerts antidepressant effects and is associated with al… Journal of affective disorders 2026-07-18 15:45:43 Source
Exploration — prudence

Pistes exploratoires 0

Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.

Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Aucune piste exploratoire ne correspond aux filtres.